Wells Fargo
NMRD

Wells Fargo’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Wells Fargo’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,163
Closed -$912 – 7830
2023
Q4 		$912 Buy
4,163
+5
+0.1% +$1 ﹤0.01% 6245
2023
Q3 		$1.31K Buy
4,158
+2
+0% +$1 ﹤0.01% 6156
2023
Q2 		$3.84K Buy
4,156
+4
+0.1% +$3 ﹤0.01% 6114
2023
Q1 		$3.72K Buy
4,152
+1,035
+33% +$1.34K ﹤0.01% 6116
2022
Q4 		$5.35K Buy
3,117
+1
+0% +$2 ﹤0.01% 5752
2022
Q3 		$6K Buy
3,116
+3
+0.1% +$6 ﹤0.01% 5876
2022
Q2 		$8K Buy
3,113
+7
+0.2% +$22 ﹤0.01% 5862
2022
Q1 		$13K Buy
3,106
+2,050
+194% +$8.57K ﹤0.01% 6188
2021
Q4 		$5K Buy
1,056
+1,000
+1,786% +$5.38K ﹤0.01% 6719
2021
Q3 		$0 Hold
56
– – ﹤0.01% 7716
2021
Q2 		$1K Sell
56
-2,344
-98% -$22.4K ﹤0.01% 6784
2021
Q1 		$19K Sell
2,400
-5,020
-68% -$33.2K ﹤0.01% 6180
2020
Q4 		$28K Buy
7,420
+2,594
+54% +$10K ﹤0.01% 5768
2020
Q3 		$17K Buy
4,826
+1,420
+42% +$8.29K ﹤0.01% 5795
2020
Q2 		$32K Buy
+3,406
New +$24.3K ﹤0.01% 5599

Other funds holding NMRD

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Wells Fargo's NMRD Position: Q1 2024 in Review

Wells Fargo sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 4,163 shares — an estimated $912 sold.

Wells Fargo first reported a position in NMRD in Q2 2020 and held it in 15 quarters. The position peaked at $32K in Q2 2020. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

  • Wells Fargo reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Wells Fargo sold 4,163 Nemaura Medical, Inc. Common Stock shares in Q1 2024, an estimated $912.
  • Wells Fargo first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • Wells Fargo's Nemaura Medical, Inc. Common Stock position peaked at $32K in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.